Skip to main contentAll experts

Rhoel Dinglasan

PROF

VM-INFECT DISEASE & IMMUNOLOGY

Orcid identifier0000-0001-5433-8179 (opens in a new tab)⁠
  • PROF
    VM-INFECT DISEASE & IMMUNOLOGY

GRANTS

  • GRANT
    West-Central Africa EMERGENTS International Center of Excellence in Malaria Research (ICEMR): Subaward to Centre for Research in Infectious Diseases in Cameroon
    National Institute of Health Niaid12 Jun 2026 - 31 Mar 2029
    Active
  • GRANT
    West-Central Africa EMERGENTS International Center of Excellence in Malaria Research (ICEMR): Subaward to The Institute for Genomics and Global Health (IGH) in Nigeria
    National Institute of Health Niaid12 Jun 2026 - 31 Mar 2029
    Active
  • GRANT
    MTEC-25-04-MultiTopic-054; ARBO-X: A Xenosurveillance Platform for Assessing, Detecting, and Preventing In-Country and Transborder Transmission of Arboviruses
    Naval Medical Research Command22 Sep 2025 - 30 Sep 2028
    Active
  • GRANT
    West-Central Africa EMERGENTS International Center of Excellence in Malaria Research (ICEMR)
    National Institute of Health Niaid22 Apr 2024 - 31 Mar 2029
    Active
  • GRANT
    Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline
    23 Dec 2022 - 26 Jul 2022
    Expired
  • GRANT
    Xenosurveillance of Flies in Wet Markets to Monitor for the Emergence and Spillover Potential of Viral, Bacterial, and Parasitic Pathogens
    US Department of Agriculture Ag Research Svc14 Sep 2022 - 31 Aug 2025
    Expired
  • GRANT
    Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline
    National Institute of Health Niaid25 Jul 2022 - 30 Jun 2027
    Active
  • GRANT
    CDC Southeastern Center of Excellence in Vector-Borne Diseases: Gateway Program
    Centers for Disease Control and Prevention19 Jun 2022 - 30 Jun 2027
    Active
  • GRANT
    COVID-19: SICA Study: Seroepidemiological Insight into COVID-19 transmission in Africa
    Centers for Disease Control and Prevention19 Aug 2021 - 30 Aug 2024
    Expired
  • GRANT
    First-In-Human Trial of the Pan-Malaria Transmission-Blocking Vaccine AnAPN1
    Global Health Innovative Technology Fund15 Mar 2021 - 30 Sep 2025
    Expired
  • GRANT
    Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
    National Institute of Health Niaid16 Feb 2021 - 28 Feb 2023
    Expired
  • GRANT
    RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives: DRC Diversity Supplement
    National Institute of Health Niaid24 Jan 2021 - 31 Jan 2024
    Expired
  • GRANT
    Commercial development of a Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART-1)
    Global Health Innovative Technology Fund13 Sep 2019 - 30 Jun 2022
    Expired
  • GRANT
    Tranexamic acid project
    Tranexamic Technologies19 Jul 2019 - 31 Jul 2020
    Expired
  • GRANT
    Saliva-based Electrochemical Paper Microfluidic Malaria Rapid Test for Early Detection and Exclusion in Point-of-Need (PON) and Clinical Settings
    National Institute of Health Niaid1 Aug 2018 - 31 Jul 2019
    Expired
  • GRANT
    Determinants of malaria transmission by submicroscopic gametocytemia
    National Institute of Health Niaid22 Jun 2018 - 31 May 2023
    Expired
  • GRANT
    Process Development and Clinical Manufacturing of an Immuno-focused, Mosquito-based Pan-malaria transmission-blocking vaccine: AnAPN1 v. 2.0.
    Global Health Innovative Technology Fund8 Mar 2018 - 31 Mar 2020
    Expired
  • GRANT
    Communicating with Local Officials and the Public about Mosquito Control
    Centers for Disease Control and Prevention27 Feb 2018 - 31 Jul 2018
    Expired
  • GRANT
    RDT-undetectable Malaria in the DR Congo
    National Institute of Health Niaid22 Feb 2018 - 31 Jan 2024
    Expired
  • GRANT
    RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives (opens in a new tab)⁠
    National Institute of Allergy and Infectious Diseases22 Feb 2018 - 31 Jan 2024
    People funded by this grant:
    • JULIANO JJ,
    • DINGLASAN RDR,
    • MESHNICK SR
    MORELEARN MORE (opens in a new tab)
  • GRANT
    Southeastern Regional CoE in Vector-Borne Diseases: The Gateway Program
    Centers for Disease Control and Prevention13 Dec 2016 - 30 Jun 2022
    Expired
  • GRANT
    A biodegradable nano-microparticle prime-boost vaccine strategy
    National Institute of Health Niaid1 Jul 2016 - 31 Mar 2021
    Expired
  • GRANT
    Function and Mechanism of O-Fucosylation of Malaria Parasite TSR Domain Proteins
    National Institute of Health Niaid1 Jul 2016 - 30 Nov 2017
    Expired
  • GRANT
    Lead optimization of an evolution-proof malaria transmission -blocking vaccine immunogen that is based on a mosquito protein target and effective against both P. falciparurm and P. vivax
    Global Health Innovative Technology Fund12 Apr 2016 - 30 Jun 2017
    Expired
  • GRANT
    Midgut Transcriptome and Proteome Analyses: Non-model Anopheline Malaria Vectors (opens in a new tab)⁠
    National Institute of Allergy and Infectious Diseases1 Jul 2014 - 30 Jun 2017
    People funded by this grant:
    • DINGLASAN RDR
    MORELEARN MORE (opens in a new tab)